Self-assembling cerebral blood vessels: 3D model offers advances in Alzheimer's treatment
A 3D model accurately mimicking the blood-brain barrier (BBB) in a laboratory environment has been successfully developed by ...
Science Daily1 小时
Self-assembling cerebral blood vessels: A breakthrough in Alzheimer's treatment
A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.
Medindia7 小时
New 3D Model Mimics Blood-Brain Barrier Pathways
Discover how a revolutionary 3D Blood-Brain Barrier model advances the understanding of neurodegenerative diseases and drug ...
GEN1 天
Optimizing AAV Gene Delivery: Hitting the Target Safely and Effectively
Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.
technologynetworks3 天
Five Years Later: Long COVID’s Lasting Impact on the Brain
Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this ...
Planet TV Studios Unveils New 'New Frontiers' Episode Featuring Neonc Technologies Holdings ...
NeOnc Technologies Holdings, Inc. Planet TV Studios New Frontiers New Frontiers features NeOnc Technologies' breakthroughs ...
Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...
Top Picks 2025- Skye Bioscience SKYE
We are recommending Skye Bioscience Inc. (SKYE) as our next investment opportunity in treating metabolic disease/obesity. Skye is developing a peripheral restricted CB1 antibody — nimacimab — to treat ...